Waning and boosting of functional humoral immunity to SARS-CoV-2

Since the emergence of the SARS-CoV-2 virus, we have witnessed a revolution in vaccine development with the rapid emergence and deployment of both traditional and novel vaccine platforms. The inactivated CoronaVac vaccine and the mRNA-based Pfizer/BNT162b2 vaccine are among the most widely distribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, X., McNamara, R.P., Avendaño, M.J., Serrano, E.F., García-Salum, T., Pardo-Roa, C., Levican, J., Poblete, E., Salina, E., Muñoz, A., Riquelme, A., Alter, G., Medina, R.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347272/
https://www.ncbi.nlm.nih.gov/pubmed/35923313
http://dx.doi.org/10.1101/2022.07.22.501163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347272/
https://www.ncbi.nlm.nih.gov/pubmed/35923313
http://dx.doi.org/10.1101/2022.07.22.501163

Ejemplares similares